Jan I S, Hsueh P R, Teng L J, Lee L N, Yang P C, Luh K T
Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
J Formos Med Assoc. 1998 Mar;97(3):204-9.
We evaluated the performance of an automatic polymerase chain reaction (PCR) detection system for identification of Mycobacterium tuberculosis in respiratory specimens. Six hundred and two respiratory specimens, including 557 sputa and 45 bronchial washing samples, were analyzed using the COBAS AMPLICOR Mycobacterium tuberculosis (MTB) test. The results were compared with those obtained from acid-fast microscopy, conventional culture, and clinical history. In cases of discrepancy between the results of the COBAS AMPLICOR MTB test and culture, the medical history of the patient was reviewed, the COBAS AMPLICOR MTB test was repeated, and the gene encoding M. tuberculosis superoxide dismutase was screened using PCR (SOD-PCR). Fourteen samples were excluded because the internal control test result was negative. Of 57 specimens that were culture positive for Mycobacterium species, 40 appeared to have growth of M. tuberculosis and 21 were smear positive for acid-fast bacteria. The sensitivity, specificity, and positive and negative predictive values for the COBAS AMPLICOR MTB test evaluated at our laboratory were 85.0% (34/40), 99.3% (544/548), 89.5% (34/38), and 98.9% (544/550), respectively. Three specimens that were culture positive for M. tuberculosis but negative by COBAS AMPLICOR MTB test were positive when rechecked by both COBAS AMPLICOR MTB test and SOD-PCR. Among the four specimens with positive reactions on both COBAS AMPLICOR MTB test and SOD-PCR that were culture negative, two were from patients who had been receiving antituberculosis treatment, one was from a patient who had been treated for tuberculosis for 1 year, and the other was from a patient who died of sepsis with adult respiratory distress syndrome. In more than 70% of smear-negative and culture-positive specimens and 86.4% of smear-positive specimens, M. tuberculosis was identified by the COBAS AMPLICOR MTB test within 10 hours after receipt of the specimens. Our data show that the COBAS AMPLICOR MTB test provides rapid and accurate detection of M. tuberculosis in respiratory specimens.
我们评估了一种自动聚合酶链反应(PCR)检测系统在呼吸道标本中鉴定结核分枝杆菌的性能。使用COBAS AMPLICOR结核分枝杆菌(MTB)检测法对602份呼吸道标本进行了分析,其中包括557份痰液和45份支气管冲洗样本。将结果与抗酸染色显微镜检查、传统培养及临床病史结果进行了比较。若COBAS AMPLICOR MTB检测结果与培养结果存在差异,则复查患者的病史,重复进行COBAS AMPLICOR MTB检测,并使用PCR(超氧化物歧化酶-PCR,SOD-PCR)筛查结核分枝杆菌超氧化物歧化酶编码基因。因内部对照检测结果为阴性,排除了14份样本。在57份分枝杆菌属培养阳性的标本中,40份似乎有结核分枝杆菌生长,21份抗酸菌涂片阳性。我们实验室评估的COBAS AMPLICOR MTB检测的敏感性、特异性、阳性预测值和阴性预测值分别为85.0%(34/40)、99.3%(544/548)、89.5%(34/38)和98.9%(544/550)。3份结核分枝杆菌培养阳性但COBAS AMPLICOR MTB检测阴性的标本,经COBAS AMPLICOR MTB检测和SOD-PCR复查后呈阳性。在COBAS AMPLICOR MTB检测和SOD-PCR均呈阳性反应但培养阴性的4份标本中,2份来自正在接受抗结核治疗的患者,1份来自已接受1年结核病治疗的患者,另1份来自死于脓毒症合并成人呼吸窘迫综合征的患者。在超过70%的涂片阴性且培养阳性的标本以及86.4%的涂片阳性标本中,在收到标本后的10小时内通过COBAS AMPLICOR MTB检测鉴定出了结核分枝杆菌。我们的数据表明,COBAS AMPLICOR MTB检测能够快速、准确地检测呼吸道标本中的结核分枝杆菌。